These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2847098

  • 1. Chemotherapy consisting of epirubicin, cisplatin, and etoposide followed by irradiation in stage III non-small cell lung cancer and chemotherapy alone in stage IV non-small cell lung cancer.
    Wils J, Utama I, Smeets J.
    Oncology; 1988; 45(6):413-6. PubMed ID: 2847098
    [Abstract] [Full Text] [Related]

  • 2. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Comella P, Scoppa G, Daponte A, Musetta G, Anania C, Maiorino A, Curcio C, Casaretti R, Comella G.
    Cancer; 1994 Oct 01; 74(7):1874-81. PubMed ID: 8082093
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
    Filipazzi V, Cattaneo MT, Rho B, Frontini L, D'Adda D, Isa L, Scapaticci R, Legnani W, Calzavara MP, Berni F.
    Oncology; 1993 Oct 01; 50(1):10-3. PubMed ID: 8380632
    [Abstract] [Full Text] [Related]

  • 4. Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).
    Phernambucq EC, Biesma B, Smit EF, Paul MA, vd Tol A, Schramel FM, Bolhuis RJ, Postmus PE.
    Br J Cancer; 2006 Aug 21; 95(4):470-4. PubMed ID: 16909132
    [Abstract] [Full Text] [Related]

  • 5. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188.
    Lokich J, Auerbach M, Essig L, Fryer J, Fryer D.
    J Infus Chemother; 1995 Aug 21; 5(2):70-2. PubMed ID: 8521238
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.
    Greco FA, Stroup SL, Gray JR, Hainsworth JD.
    J Clin Oncol; 1996 May 21; 14(5):1642-8. PubMed ID: 8622083
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, Boye N, Wang M, Vigander T, Vilsvik J, Skovlund E, Hannisdal E, Aamdal S, Norwegian Lung Cancer Study Group.
    J Clin Oncol; 2002 Dec 15; 20(24):4665-72. PubMed ID: 12488411
    [Abstract] [Full Text] [Related]

  • 8. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun 15; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 9. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb 15; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 10. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    Rice TW, Adelstein DJ, Koka A, Tefft M, Kirby TJ, Van Kirk MA, Taylor ME, Olencki TE, Peereboom D, Budd GT.
    Ann Thorac Surg; 1995 Sep 15; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
    [Abstract] [Full Text] [Related]

  • 11. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Le Péchoux C, Arriagada R, Le Chevalier T.
    Cancer; 1995 Aug 01; 76(3):530-1. PubMed ID: 8625139
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
    Bonomi P, Kim K, Fairclough D, Cella D, Kugler J, Rowinsky E, Jiroutek M, Johnson D.
    J Clin Oncol; 2000 Feb 01; 18(3):623-31. PubMed ID: 10653877
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 14. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.
    Jpn J Clin Oncol; 1994 Oct 01; 24(5):275-81. PubMed ID: 7967106
    [Abstract] [Full Text] [Related]

  • 15. Concurrent cisplatin and etoposide with radiotherapy in locally advanced non-small cell lung cancer.
    Friess GG, Baikadi M, Harvey WH.
    Cancer Treat Rep; 1987 Oct 01; 71(7-8):681-4. PubMed ID: 3038313
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancer.
    Iacobelli S, Irtelli L, Sacco R, Martino M, Mascitelli E, Basilico L, Scognamiglio M, Natoli C, Fusco O, Tinari N, Beltrami V.
    Anticancer Res; 1998 Oct 01; 18(3B):2081-4. PubMed ID: 9677471
    [Abstract] [Full Text] [Related]

  • 17. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Frommhold H, Pressler K, Mertelsmann R, Kanz L.
    Semin Oncol; 1995 Feb 01; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [Abstract] [Full Text] [Related]

  • 18. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 01; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 19. Infusional cisplatin and etoposide in the treatment of stage III-B and IV non-small cell lung cancer: a well tolerated regimen.
    Glynn P, Higby D, Moriarty E, Ficalora M, Volpe B, Koletsky A, White C.
    J Med; 1994 May 01; 25(3-4):193-201. PubMed ID: 7996063
    [Abstract] [Full Text] [Related]

  • 20. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.
    Albain KS, Crowley JJ, Turrisi AT, Gandara DR, Farrar WB, Clark JI, Beasley KR, Livingston RB.
    J Clin Oncol; 2002 Aug 15; 20(16):3454-60. PubMed ID: 12177106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.